Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 179.40K | 175.70K | 267.30K | 274.90K | 102.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 179.40K | 175.70K | 267.30K | 274.90K | 102.90K |
| Cost of Revenue | 52.90K | 51.80K | 115.90K | 119.20K | 34.60K |
| Gross Profit | 126.50K | 123.90K | 151.40K | 155.70K | 68.30K |
| SG&A Expenses | 543.90K | 532.60K | 287.60K | 295.70K | 381.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.01M | 993.50K | 559.00K | 574.80K | 817.70K |
| Operating Income | -835.10K | -817.80K | -291.70K | -299.90K | -714.90K |
| Income Before Tax | -857.10K | -839.30K | -308.50K | -317.20K | -716.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -857.10K | -839.30K | -308.50K | -317.20K | -716.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -857.10K | -839.30K | -308.50K | -317.20K | -716.70K |
| EBIT | -835.10K | -817.80K | -291.70K | -299.90K | -714.90K |
| EBITDA | -813.20K | -796.30K | -268.80K | -276.40K | -690.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.17B | 3.17B | 3.17B | 3.17B | 3.17B |
| Average Diluted Shares Outstanding | 3.17B | 3.17B | 3.17B | 3.17B | 3.17B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |